JP2011503072A5 - - Google Patents

Download PDF

Info

Publication number
JP2011503072A5
JP2011503072A5 JP2010533127A JP2010533127A JP2011503072A5 JP 2011503072 A5 JP2011503072 A5 JP 2011503072A5 JP 2010533127 A JP2010533127 A JP 2010533127A JP 2010533127 A JP2010533127 A JP 2010533127A JP 2011503072 A5 JP2011503072 A5 JP 2011503072A5
Authority
JP
Japan
Prior art keywords
methyl
ethyl
carboxylic acid
fluoro
amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010533127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011503072A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/012763 external-priority patent/WO2009064449A1/en
Publication of JP2011503072A publication Critical patent/JP2011503072A/ja
Publication of JP2011503072A5 publication Critical patent/JP2011503072A5/ja
Pending legal-status Critical Current

Links

JP2010533127A 2007-11-13 2008-11-13 イオンチャネルのリガンドとしてのアミド誘導体ならびにそれを使用する薬学的組成物および方法 Pending JP2011503072A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US283807P 2007-11-13 2007-11-13
PCT/US2008/012763 WO2009064449A1 (en) 2007-11-13 2008-11-13 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Publications (2)

Publication Number Publication Date
JP2011503072A JP2011503072A (ja) 2011-01-27
JP2011503072A5 true JP2011503072A5 (enExample) 2011-12-22

Family

ID=40427444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010533127A Pending JP2011503072A (ja) 2007-11-13 2008-11-13 イオンチャネルのリガンドとしてのアミド誘導体ならびにそれを使用する薬学的組成物および方法

Country Status (7)

Country Link
US (1) US8153651B2 (enExample)
EP (1) EP2215054B8 (enExample)
JP (1) JP2011503072A (enExample)
AT (1) ATE522500T1 (enExample)
CA (1) CA2703220A1 (enExample)
ES (1) ES2372655T3 (enExample)
WO (1) WO2009064449A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010056044A2 (ko) * 2008-11-11 2010-05-20 (주)아모레퍼시픽 바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물
KR101645537B1 (ko) * 2008-11-11 2016-08-05 (주)아모레퍼시픽 바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물
US8957254B2 (en) 2009-07-06 2015-02-17 Solvay Sa Process for chemical synthesis from an alkenone made from a halogenated precursor
WO2017095724A1 (en) * 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
WO2017095725A1 (en) * 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
RU2624903C1 (ru) * 2016-11-02 2017-07-10 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Производные ванилина с противоопухолевой активностью
US11046683B2 (en) 2016-12-15 2021-06-29 Ono Pharmaceutical Co., Ltd. Activator of TREK (TWIK RElated K+ channels) channels
HUE064575T2 (hu) 2017-03-13 2024-04-28 Raqualia Pharma Inc Tetrahidrokinolin-származékok mint P2X7 receptorantagonisák
KR102622654B1 (ko) * 2021-02-22 2024-01-10 연세대학교 산학협력단 항염증용 조성물
US12099904B2 (en) 2021-03-10 2024-09-24 International Business Machines Corporation Uniform artificial intelligence model conversion

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD287263A5 (de) 1989-08-29 1991-02-21 Akademie Der Wissenschaften Der Ddr,De Verfahren zur herstellung von 6-(pyrid-4-yl)-1,2,4-triazolo-[1,5-a] pyridinen
WO1998045268A1 (en) * 1997-04-04 1998-10-15 Pfizer Products Inc. Nicotinamide derivatives
AU8022901A (en) * 2000-08-21 2002-03-04 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
KR100707123B1 (ko) * 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
JP2008531690A (ja) * 2005-02-28 2008-08-14 レノビス， インコーポレイテッド イオンチャネルリガンドとしてのアミド誘導体並びにそれを使用する医薬組成物及び方法
BRPI0608436A2 (pt) * 2005-03-17 2009-12-29 Pfizer derivados de n-(n-sulfonilaminometil) ciclopropanocarboxamida utilizáveis para o tratamento de dor
DE602005004276T2 (de) 2005-07-22 2008-12-24 Institute Of Electronics And Computer Science Of Latvian University Für unregelmäßiges Abtasten geeignetes Verfahren und Vorrichtung zur Spektralschätzung
DOP2006000210A (es) * 2005-10-04 2007-06-15 Aventis Pharma Inc Compuestos de pirimidina amida como inhibidores de pgds
WO2007133637A2 (en) * 2006-05-10 2007-11-22 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
CA2662074A1 (en) 2006-08-30 2008-03-06 Cellzome Limited Triazole derivatives as kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2011503072A5 (enExample)
AU735137B2 (en) Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders
JP5733982B2 (ja) サイトカインの産生を抑制する化合物及びその調製方法
JP2009541206A5 (enExample)
JP2009530304A5 (enExample)
JP2009530302A5 (enExample)
JP2007509043A5 (enExample)
EP1708992B1 (en) Sulfonamide derivatives for the treatment of diseases
TWI333950B (en) New benzimidazole derivatives
RU2018138183A (ru) Оксистеролы и способы их применения
JP2010524930A5 (enExample)
CN113773300B (zh) 磺酰胺类化合物、其制备方法及用途
NO320321B1 (no) Fenyl- og pyridinylderivater, anvendelse og fremstilling derav samt medikament.
CN102159535A (zh) 钾离子通道调节剂及其用途
JP2021518388A (ja) オキサジアゾール一過性受容器電位チャネル阻害剤
JP2010530425A (ja) Ｃｒｔｈ２アンタゴニストの粒子
CA3063111A1 (en) Histone deacetylases (hdacs) inhibitors
JP7167236B2 (ja) せん妄の予防または治療剤
TWI440461B (zh) １ｈ-喹唑啉-２，４-二酮
JP2011509296A5 (enExample)
RU2007125659A (ru) Фенилпиперазиновые производные с сочетанием свойств неполного агонизма к рецепторам дофамина-d2 и ингибирования повторного поглощения серотонина
CA2903464A1 (en) Treatment of cancer and other conditions using a transcription factor modulator
BRPI0615631A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
JP2002528534A (ja) 医薬化合物
CN113149894B (zh) (e)-3-芳杂环基丙-2-烯酸衍生物的制药用途